Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Escherichia coli |
0.031 |
0.5 |
≤0.004 - 2 |
Gatifloxacin (Tequin) |
443 |
Escherichia coli |
0.032 |
0.063 |
0.016 - 0.125 |
Cefpirome |
952 |
Escherichia coli |
0.032 |
0.063 |
0.032 - 0.063 |
Biapenem |
952 |
Escherichia coli |
0.045 |
0.091 |
? - ? |
Ceftobiprole (Zeftera) |
942 |
Escherichia coli |
0.05 |
0.1 |
≤0.00625 - 0.2 |
Garenoxacin (T-3811, BMS-284756) |
17 |
Escherichia coli |
0.05 |
25 |
≤0.025 - 50 |
Levofloxacin (Levaquin, Quixin) |
40 |
Escherichia coli |
0.06 |
0.06 |
0.03 - 0.12 |
Sparfloxacin (AT-4140, Zagam) |
374 |
Escherichia coli |
0.06 |
0.06 |
0.03 - 0.25 |
Cefotaxime (Cephotaxime, Claforan) |
1438 |
Escherichia coli |
0.06 |
0.12 |
≤0.007 - 64 |
Cefotaxime (Cephotaxime, Claforan) |
113 |
Escherichia coli |
0.06 |
0.12 |
0.015 - 2 |
Cefmenoxime |
1438 |
Escherichia coli |
0.06 |
0.12 |
≤0.06 - >8 |
Ceftriaxone (Rocephin) |
462 |
Escherichia coli |
0.06 |
0.12 |
? - ? |
Cefotaxime (Cephotaxime, Claforan) |
1389 |
Escherichia coli |
0.06 |
0.125 |
0.016 - 0.125 |
Levofloxacin (Levaquin, Quixin) |
317 |
Escherichia coli |
0.06 |
0.13 |
? - ? |
Ceftriaxone (Rocephin) |
1111 |
Escherichia coli |
0.06 |
0.25 |
0.015 - 8 |
Ceftibuten (Cedax) |
274 |
Escherichia coli |
0.06 |
0.25 |
0.03 - 2 |
FK037 |
1491 |
Escherichia coli |
0.06 |
0.25 |
<0.03 - >128 |
LY127935 |
1434 |
Escherichia coli |
0.06 |
0.25 |
≤0.06 - >64 |
Ceftriaxone (Rocephin) |
42 |
Escherichia coli |
0.06 |
0.25 |
≤0.06 - >=128 |
Ceftriaxone (Rocephin) |
475 |
Escherichia coli |
0.06 |
0.25 |
? - ? |
Cefmenoxime |
1389 |
Escherichia coli |
0.06 |
0.25 |
? - ? |
Moxalactam (Latamoxef) |
1389 |
Escherichia coli |
0.06 |
0.5 |
≤0.06 - >32 |
Meropenem (Merrem) |
1371 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
443 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 16 |
Garenoxacin (T-3811, BMS-284756) |
443 |
Escherichia coli |
0.06 |
1 |
≤0.004 - 16 |
Garenoxacin (T-3811, BMS-284756) |
130 |
Escherichia coli |
0.06 |
1 |
0.015 - >64 |
Garenoxacin (T-3811, BMS-284756) |
225 |
Escherichia coli |
0.06 |
2 |
0.06 - ? |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
946 |